Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -7.51% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 27.27%. Over the past 30 days, the price of REPL has leaped by -14.18%. And in the last five days, it has fallen by -9.16%.
Replimune Group Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $17.00 on 11/22/24 and the lowest value was $4.92 on 05/29/24.
52-week price history of REPL Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Replimune Group Inc’s current trading price is -34.12% away from its 52-week high, while its distance from the 52-week low is 127.64%. The stock’s price range during this period has varied between$4.92 and $17.00. The Replimune Group Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.67 million for the day, a figure considerably lower than their average daily volume of 0.78 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Replimune Group Inc (REPL) has experienced a quarterly decline of -1.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 843.81M and boasts a workforce of 331 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.65, with a change in price of +1.34. Similarly, Replimune Group Inc recorded 775,702 in trading volume during the last 100 days, posting a change of +13.59%.
REPL’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for REPL stands at 0.20. Similarly, the long-term debt-to-equity ratio is also 0.19.
REPL Stock Stochastic Average
As of today, Replimune Group Inc’s raw stochastic average for the last 50 days stands at 9.80%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 5.98%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 33.78% and 44.89%, respectively.
